1. Find new tests in blood, urine, semen, or biopsy (or surgery) samples that can tell if a patient has prostate cancer.
2. Find tests that can identify aggressive cancers.
To discover these tests, blood, urine, semen and clinical information from close to 4000 men are required. We plan to enroll patients over a period of 5 years in Calgary and Edmonton.
In Calgary, recruitment will occur at the Prostate Cancer Centre and Tom Baker Cancer Centre. In addition, participants may join the study by contacting the Calgary study coordinator at 403-943-8942.
In Edmonton, recruitment will occur at the Northern Alberta Urology Centre and Cross Cancer Institute. In addition, participants may join the study by contacting the Edmonton study coordinator at 780-407-5914.
Ask your doctor if you are eligible to participate in the study!
Download the Alberta Prostate Registry and Biorepository Information Brochure.
Download the Alberta Prostate Cancer Registry and Biorepository Information Brochure.
Cancer Control Alberta reduces the impact of cancer on all Albertans and provides expert care and support for patients from their first symptom to survivorship. Supporting world-class research are two specialized teams that operate within the Clinical Trials Units at the Cross Cancer Institute and the Tom Baker Cancer Centre. Each team provides well-trained staff and comprehensive services to researchers who are conducting clinical trials. In addition to the cancer centres, The Prostate Cancer Centre in Calgary and the Northern Alberta Urology Centre in Edmonton are testing advances in diagnosis and treatment to improve quality of life and work towards a cure for prostate cancer.
Congratulations to John Lewis and Nanostics for winning an entry into the highly competitive and prestigious Falling Walls Venture Conference in Berlin, November 8-9, 2018!
Five presenters pitched their healthcare-related ideas and innovations to a panel of tech and business-savvy judges and a large audience on Aug 29, 2018, at the University of Alberta in a high-stakes “TEDTalk” meets “Dragon’s Den” style. The competition was tough but John Lewis edged out the fellow contenders to win a chance to pitch a 5-minute talk on Nanostics’ high-accuracy prostate cancer diagnostic reflex test: ClarityDX Prostate.
John talked with Mark Connolly from the CBC Edmonton Morning show on September 4 about the Falling Walls competition and what he is preparing for this November.
Good luck to John Lewis at the Falling Walls Finale in Berlin!
